United States Molecular Diagnostics in Infectious Disease Testing Industry 2016 Deep Market Research Report
- QYR565232
- 137 Pages
- April 2016
- Diagnostic and Biotech
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Molecular Diagnostics in Infectious Disease Testing market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Molecular Diagnostics in Infectious Disease Testing industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 150 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Industry Overview
1.1 Definition and Specifications of Molecular Diagnostics in Infectious Disease Testing
1.1.1 Definition of Molecular Diagnostics in Infectious Disease Testing
1.1.2 Specifications of Molecular Diagnostics in Infectious Disease Testing
1.2 Classification of Molecular Diagnostics in Infectious Disease Testing
1.3 Applications of Molecular Diagnostics in Infectious Disease Testing
1.4 Industry Chain Structure of Molecular Diagnostics in Infectious Disease Testing
1.5 Industry Overview of Molecular Diagnostics in Infectious Disease Testing
1.6 Industry Policy Analysis of Molecular Diagnostics in Infectious Disease Testing
1.7 Industry News Analysis of Molecular Diagnostics in Infectious Disease Testing
2 Manufacturing Cost Structure Analysis of Molecular Diagnostics in Infectious Disease Testing
2.1 Bill of Materials (BOM) of Molecular Diagnostics in Infectious Disease Testing
2.2 BOM Price Analysis of Molecular Diagnostics in Infectious Disease Testing
2.3 Labor Cost Analysis of Molecular Diagnostics in Infectious Disease Testing
2.4 Depreciation Cost Analysis of Molecular Diagnostics in Infectious Disease Testing
2.5 Manufacturing Cost Structure Analysis of Molecular Diagnostics in Infectious Disease Testing
2.6 Manufacturing Process Analysis of Molecular Diagnostics in Infectious Disease Testing
2.7 United States Price, Cost and Gross of Molecular Diagnostics in Infectious Disease Testing 2011-2016
3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015
3.2 Manufacturing Plants Distribution of United States Key Molecular Diagnostics in Infectious Disease Testing Manufacturers in 2015
3.3 R&D Status and Technology Source of United States Molecular Diagnostics in Infectious Disease Testing Key Manufacturers in 2015
3.4 Raw Materials Sources Analysis of United States Molecular Diagnostics in Infectious Disease Testing Key Manufacturers in 2015
4 Production Analysis of Molecular Diagnostics in Infectious Disease Testing by Regions, Type, and Applications
4.1 United States Production of Molecular Diagnostics in Infectious Disease Testing by Regions 2011-2016
4.2 United States Production of Molecular Diagnostics in Infectious Disease Testing by Type 2011-2016
4.3 United States Sales of Molecular Diagnostics in Infectious Disease Testing by Applications 2011-2016
4.4 Price Analysis of United States Molecular Diagnostics in Infectious Disease Testing Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Molecular Diagnostics in Infectious Disease Testing 2011-2016
5 Consumption Volume and Consumption Value Analysis of Molecular Diagnostics in Infectious Disease Testing by Regions
5.1 United States Consumption Volume of Molecular Diagnostics in Infectious Disease Testing by Regions 2011-2016
5.2 United States Consumption Value of Molecular Diagnostics in Infectious Disease Testing by Regions 2011-2016
5.3 United States Consumption Price Analysis of Molecular Diagnostics in Infectious Disease Testing by Regions 2011-2016
6 Analysis of Molecular Diagnostics in Infectious Disease Testing Production, Supply, Sales and Market Status 2011-2016
6.1 Capacity, Production, Sales, and Revenue of Molecular Diagnostics in Infectious Disease Testing 2011-2016
6.2 Production Market Share and Sales Market Share Analysis of Molecular Diagnostics in Infectious Disease Testing 2014-2015
6.3 Sales Overview of Molecular Diagnostics in Infectious Disease Testing 2011-2016
6.4 Supply, Consumption and Gap of Molecular Diagnostics in Infectious Disease Testing 2011-2016
6.5 Import, Export and Consumption of Molecular Diagnostics in Infectious Disease Testing 2011-2016
6.6 Cost, Price, Revenue and Gross Margin of Molecular Diagnostics in Infectious Disease Testing 2011-2016
7 Analysis of Molecular Diagnostics in Infectious Disease Testing Industry Key Manufacturers
7.1 Abbott Laboratories
7.1.1 Company Profile
7.1.2 Product Picture and Specifications
7.1.2.1 Type I
7.1.2.2 Type II
7.1.2.3 Type III
7.1.3 Capacity, Production, Price, Cost, Gross and Revenue
7.1.4 Contact Information
7.2 Affymetrix
7.2.1 Company Profile
7.2.2 Product Picture and Specifications
7.2.2.1 Type I
7.2.2.2 Type II
7.2.2.3 Type III
7.2.3 Capacity, Production, Price, Cost, Gross and Revenue
7.2.4 Contact Information
7.3 AdvanDx
7.3.1 Company Profile
7.3.2 Product Picture and Specifications
7.3.2.1 Type I
7.3.2.2 Type II
7.3.2.3 Type III
7.3.3 Capacity, Production, Price, Cost, Gross and Revenue
7.3.4 Contact Information
7.4 Arcxis Biotechnologies
7.4.1 Company Profile
7.4.2 Product Picture and Specifications
7.4.2.1 Type I
7.4.2.2 Type II
7.4.2.3 Type III
7.4.3 Capacity, Production, Price, Cost, Gross and Revenue
7.4.4 Contact Information
7.5 Asuragen
7.5.1 Company Profile
7.5.2 Product Picture and Specifications
7.5.2.1 Type I
7.5.2.2 Type II
7.5.2.3 Type III
7.5.3 Capacity, Production, Price, Cost, Gross and Revenue
7.5.4 Contact Information
7.6 AutoGenomics
7.6.1 Company Profile
7.6.2 Product Picture and Specifications
7.6.2.1 Type I
7.6.2.2 Type II
7.6.2.3 Type III
7.6.3 Capacity, Production, Price, Cost, Gross and Revenue
7.6.4 Contact Information
7.7 Becton, Dickinson
7.7.1 Company Profile
7.7.2 Product Picture and Specifications
7.7.2.1 Type I
7.7.2.2 Type II
7.7.2.3 Type III
7.7.3 Capacity, Production, Price, Cost, Gross and Revenue
7.7.4 Contact Information
7.8 BioMérieux
7.8.1 Company Profile
7.8.2 Product Picture and Specifications
7.8.2.1 Type I
7.8.2.2 Type II
7.8.2.3 Type III
7.8.3 Capacity, Production, Price, Cost, Gross and Revenue
7.8.4 Contact Information
7.9 Biocartis
7.9.1 Company Profile
7.9.2 Product Picture and Specifications
7.9.2.1 Type I
7.9.2.2 Type II
7.9.2.3 Type III
7.9.3 Capacity, Production, Price, Cost, Gross and Revenue
7.9.4 Contact Information
7.10 BioHelix Corporation
7.10.1 Company Profile
7.10.2 Product Picture and Specifications
7.10.2.1 Type I
7.10.2.2 Type II
7.10.2.3 Type III
7.10.3 Capacity, Production, Price, Cost, Gross and Revenue
7.10.4 Contact Information
7.11 BioTheranostics
7.11.1 Company Profile
7.11.2 Product Picture and Specifications
7.11.2.1 Type I
7.11.2.2 Type II
7.11.2.3 Type III
7.11.3 Capacity, Production, Price, Cost, Gross and Revenue
7.11.4 Contact Information
7.12 Cepheid
7.12.1 Company Profile
7.12.2 Product Picture and Specifications
7.12.2.1 Type I
7.12.2.2 Type II
7.12.2.3 Type III
7.12.3 Capacity, Production, Price, Cost, Gross and Revenue
7.12.4 Contact Information
7.13 EraGen Biosciences
7.13.1 Company Profile
7.13.2 Product Picture and Specifications
7.13.2.1 Type I
7.13.2.2 Type II
7.13.2.3 Type III
7.13.3 Capacity, Production, Price, Cost, Gross and Revenue
7.13.4 Contact Information
7.14 GenMark Diagnostics
7.14.1 Company Profile
7.14.2 Product Picture and Specifications
7.14.2.1 Type I
7.14.2.2 Type II
7.14.2.3 Type III
7.14.3 Capacity, Production, Price, Cost, Gross and Revenue
7.14.4 Contact Information
7.15 Genomix Biotech
7.15.1 Company Profile
7.15.2 Product Picture and Specifications
7.15.2.1 Type I
7.15.2.2 Type II
7.15.2.3 Type III
7.15.3 Capacity, Production, Price, Cost, Gross and Revenue
7.15.4 Contact Information
7.16 Gen-Probe
7.16.1 Company Profile
7.16.2 Product Picture and Specifications
7.16.2.1 Type I
7.16.2.2 Type II
7.16.2.3 Type III
7.16.3 Capacity, Production, Price, Cost, Gross and Revenue
7.16.4 Contact Information
7.17 Genomica S.A.U.
7.17.1 Company Profile
7.17.2 Product Picture and Specifications
7.17.2.1 Type I
7.17.2.2 Type II
7.17.2.3 Type III
7.17.3 Capacity, Production, Price, Cost, Gross and Revenue
7.17.4 Contact Information
7.18 Great Basin Corporation
7.18.1 Company Profile
7.18.2 Product Picture and Specifications
7.18.2.1 Type I
7.18.2.2 Type II
7.18.2.3 Type III
7.18.3 Capacity, Production, Price, Cost, Gross and Revenue
7.18.4 Contact Information
7.19 Illumina
7.19.1 Company Profile
7.19.2 Product Picture and Specifications
7.19.2.1 Type I
7.19.2.2 Type II
7.19.2.3 Type III
7.19.3 Capacity, Production, Price, Cost, Gross and Revenue
7.19.4 Contact Information
7.20 Life Technologies
7.20.1 Company Profile
7.20.2 Product Picture and Specifications
7.20.2.1 Type I
7.20.2.2 Type II
7.20.2.3 Type III
7.20.3 Capacity, Production, Price, Cost, Gross and Revenue
7.20.4 Contact Information
8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Molecular Diagnostics in Infectious Disease Testing Product Types
8.5 Market Share Analysis of Different Molecular Diagnostics in Infectious Disease Testing Price Levels
8.6 Gross Margin Analysis of Different Molecular Diagnostics in Infectious Disease Testing Applications
9 Marketing Trader or Distributor Analysis of Molecular Diagnostics in Infectious Disease Testing
9.1 Marketing Channels Status of Molecular Diagnostics in Infectious Disease Testing
9.2 Traders or Distributors of Molecular Diagnostics in Infectious Disease Testing with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Molecular Diagnostics in Infectious Disease Testing
9.4 United States Import, Export and Trade Analysis of Molecular Diagnostics in Infectious Disease Testing
10 Development Trend of Molecular Diagnostics in Infectious Disease Testing Industry 2016-2021
10.1 Capacity and Production Overview of Molecular Diagnostics in Infectious Disease Testing 2016-2021
10.2 Production Market Share by Product Types of Molecular Diagnostics in Infectious Disease Testing 2016-2021
10.3 Sales and Sales Revenue Overview of Molecular Diagnostics in Infectious Disease Testing 2016-2021
10.4 United States Sales of Molecular Diagnostics in Infectious Disease Testing by Applications 2016-2021
10.5 Import, Export and Consumption of Molecular Diagnostics in Infectious Disease Testing 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Molecular Diagnostics in Infectious Disease Testing 2016-2021
11 Industry Chain Suppliers of Molecular Diagnostics in Infectious Disease Testing with Contact Information
11.1 Major Raw Materials Suppliers of Molecular Diagnostics in Infectious Disease Testing with Contact Information
11.2 Manufacturing Equipment Suppliers of Molecular Diagnostics in Infectious Disease Testing with Contact Information
11.3 Major Players of Molecular Diagnostics in Infectious Disease Testing with Contact Information
11.4 Key Consumers of Molecular Diagnostics in Infectious Disease Testing with Contact Information
11.5 Supply Chain Relationship Analysis of Molecular Diagnostics in Infectious Disease Testing
12 New Project Investment Feasibility Analysis of Molecular Diagnostics in Infectious Disease Testing
12.1 New Project SWOT Analysis of Molecular Diagnostics in Infectious Disease Testing
12.2 New Project Investment Feasibility Analysis of Molecular Diagnostics in Infectious Disease Testing
13 Conclusion of the United States Molecular Diagnostics in Infectious Disease Testing Industry 2016 Market Research Report
Figure Picture of Molecular Diagnostics in Infectious Disease Testing
Table Product Specifications of Molecular Diagnostics in Infectious Disease Testing
Table Classification of Molecular Diagnostics in Infectious Disease Testing
Figure United States Sales Market Share of Molecular Diagnostics in Infectious Disease Testing by Product Types in 2015
Table Applications of Molecular Diagnostics in Infectious Disease Testing
Figure United States Sales Market Share of Molecular Diagnostics in Infectious Disease Testing by Applications in 2015
Figure Industry Chain Structure of Molecular Diagnostics in Infectious Disease Testing
Table United States Industry Overview of Molecular Diagnostics in Infectious Disease Testing
Table Industry Policy of Molecular Diagnostics in Infectious Disease Testing
Table Industry News List of Molecular Diagnostics in Infectious Disease Testing
Table Bill of Materials (BOM) of Molecular Diagnostics in Infectious Disease Testing
Table Bill of Materials (BOM) Price of Molecular Diagnostics in Infectious Disease Testing
Table Labor Cost of Molecular Diagnostics in Infectious Disease Testing
Table Depreciation Cost of Molecular Diagnostics in Infectious Disease Testing
Table Manufacturing Cost Structure Analysis of Molecular Diagnostics in Infectious Disease Testing in 2015
Figure Manufacturing Process Analysis of Molecular Diagnostics in Infectious Disease Testing
Table United States Price Analysis of Molecular Diagnostics in Infectious Disease Testing 2011-2016 (USD/Unit)
Table United States Cost Analysis of Molecular Diagnostics in Infectious Disease Testing 2011-2016 (USD/Unit)
Table United States Gross Analysis of Molecular Diagnostics in Infectious Disease Testing 2011-2016
Table Capacity (K Units) and Commercial Production Date of United States Molecular Diagnostics in Infectious Disease Testing Key Manufacturers in 2015
Table Manufacturing Plants Distribution of United States Key Molecular Diagnostics in Infectious Disease Testing Manufacturers in 2015
Table R&D Status and Technology Source of United States Molecular Diagnostics in Infectious Disease Testing Key Manufacturers in 2015
Table Raw Materials Sources Analysis of United States and United States Molecular Diagnostics in Infectious Disease Testing Key Manufacturers in 2015
Table United States Production of Molecular Diagnostics in Infectious Disease Testing by Regions 2011-2016 (K Units)
Table United States Production Market Share of Molecular Diagnostics in Infectious Disease Testing by Regions 2011-2016
Figure United States Production Market Share of Molecular Diagnostics in Infectious Disease Testing by Regions in 2014
Figure United States Production Market Share of Molecular Diagnostics in Infectious Disease Testing by Regions in 2015
Table United States Production of Molecular Diagnostics in Infectious Disease Testing by Types in 2011-2016 (K Units)
Table United States Production Market Share of Molecular Diagnostics in Infectious Disease Testing by Type in 2011-2016
Figure United States Production Market Share of Molecular Diagnostics in Infectious Disease Testing by Type in 2014
Figure United States Production Market Share of Molecular Diagnostics in Infectious Disease Testing by Type in 2015
Table United States Sales of Molecular Diagnostics in Infectious Disease Testing by Applications 2011-2016 (K Units)
Table United States Production Market Share of Molecular Diagnostics in Infectious Disease Testing by Applications 2011-2016
Figure United States Production Market Share of Molecular Diagnostics in Infectious Disease Testing by Applications in 2014
Figure United States Production Market Share of Molecular Diagnostics in Infectious Disease Testing by Applications in 2015
Table Price Comparison of United States Molecular Diagnostics in Infectious Disease Testing Key Manufacturers in 2015 (USD/Unit)
Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Molecular Diagnostics in Infectious Disease Testing 2011-2016
Table United States Consumption Volume of Molecular Diagnostics in Infectious Disease Testing by Regions 2011-2016 (K Units)
Table United States Consumption Volume Market Share of Molecular Diagnostics in Infectious Disease Testing by Regions 2011-2016
Figure United States Consumption Volume Market Share of Molecular Diagnostics in Infectious Disease Testing by Regions in 2014
Figure United States Consumption Volume Market Share of Molecular Diagnostics in Infectious Disease Testing by Regions in 2015
Table United States Consumption Value of Molecular Diagnostics in Infectious Disease Testing by Regions 2011-2016 (M USD)
Table United States Consumption Value Market Share of Molecular Diagnostics in Infectious Disease Testing by Regions 2011-2016
Figure United States Consumption Value Market Share of Molecular Diagnostics in Infectious Disease Testing by Regions in 2014
Figure United States Consumption Value Market Share of Molecular Diagnostics in Infectious Disease Testing by Regions in 2015
Table Consumption Price of Molecular Diagnostics in Infectious Disease Testing by Regions 2011-2016 (USD/Unit)
Table United States and Major Manufacturers Capacity of Molecular Diagnostics in Infectious Disease Testing 2011-2016 (K Units)
Table United States Capacity Market Share of Major Molecular Diagnostics in Infectious Disease Testing Manufacturers 2011-2016
Table United States and Major Manufacturers Production of Molecular Diagnostics in Infectious Disease Testing 2011-2016 (K Units)
Table United States Production Market Share of Major Molecular Diagnostics in Infectious Disease Testing Manufacturers 2011-2016
Table United States and Major Manufacturers Sales of Molecular Diagnostics in Infectious Disease Testing 2011-2016 (K Units)
Table United States Sales Market Share of Major Molecular Diagnostics in Infectious Disease Testing Manufacturers 2011-2016
Table United States and Major Manufacturers Sales Revenue of Molecular Diagnostics in Infectious Disease Testing 2011-2016 (M USD)
Table United States Sales Revenue Market Share of Major Molecular Diagnostics in Infectious Disease Testing Manufacturers 2011-2016
Figure United States Capacity (K Units), Production (K Units) and Growth Rate of Molecular Diagnostics in Infectious Disease Testing 2011-2016
Figure United States Capacity Utilization Rate of Molecular Diagnostics in Infectious Disease Testing 2011-2016
Figure United States Sales Revenue (M USD) and Growth Rate of Molecular Diagnostics in Infectious Disease Testing 2011-2016
Figure United States Production Market Share of Major Molecular Diagnostics in Infectious Disease Testing Manufacturers in 2014
Figure United States Production Market Share of Major Molecular Diagnostics in Infectious Disease Testing Manufacturers in 2015
Figure United States Sales Market Share of Major Molecular Diagnostics in Infectious Disease Testing Manufacturers in 2014
Figure United States Sales Market Share of Major Molecular Diagnostics in Infectious Disease Testing Manufacturers in 2015
Figure United States Sales (K Units) and Growth Rate of Molecular Diagnostics in Infectious Disease Testing 2011-2016
Table United States Supply, Consumption and Gap of Molecular Diagnostics in Infectious Disease Testing 2011-2016 (K Units)
Table United States Import, Export and Consumption of Molecular Diagnostics in Infectious Disease Testing 2011-2016 (K Units)
Table Price of United States Molecular Diagnostics in Infectious Disease Testing Major Manufacturers 2011-2016 (USD/Unit)
Table Gross Margin of United States Molecular Diagnostics in Infectious Disease Testing Major Manufacturers 2011-2016
Table United States and Major Manufacturers Revenue of Molecular Diagnostics in Infectious Disease Testing 2011-2016 (M USD)
Table United States Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Molecular Diagnostics in Infectious Disease Testing 2011-2016
Table Abbott Laboratories Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Infectious Disease Testing Picture and Specifications of Abbott Laboratories
Table Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Abbott Laboratories 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units) and Growth Rate of Abbott Laboratories 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Production (K Units) and United States Market Share of Abbott Laboratories 2011-2016
Table Abbott Laboratories Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table Affymetrix Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Infectious Disease Testing Picture and Specifications of Affymetrix
Table Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Affymetrix 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units) and Growth Rate of Affymetrix 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Production (K Units) and United States Market Share of Affymetrix 2011-2016
Table Affymetrix Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table AdvanDx Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Infectious Disease Testing Picture and Specifications of AdvanDx
Table Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of AdvanDx 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units) and Growth Rate of AdvanDx 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Production (K Units) and United States Market Share of AdvanDx 2011-2016
Table AdvanDx Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table Arcxis Biotechnologies Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Infectious Disease Testing Picture and Specifications of Arcxis Biotechnologies
Table Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Arcxis Biotechnologies 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units) and Growth Rate of Arcxis Biotechnologies 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Production (K Units) and United States Market Share of Arcxis Biotechnologies 2011-2016
Table Arcxis Biotechnologies Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table Asuragen Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Infectious Disease Testing Picture and Specifications of Asuragen
Table Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Asuragen 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units) and Growth Rate of Asuragen 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Production (K Units) and United States Market Share of Asuragen 2011-2016
Table Asuragen Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table AutoGenomics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Infectious Disease Testing Picture and Specifications of AutoGenomics
Table Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of AutoGenomics 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units) and Growth Rate of AutoGenomics 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Production (K Units) and United States Market Share of AutoGenomics 2011-2016
Table AutoGenomics Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table Becton, Dickinson Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Infectious Disease Testing Picture and Specifications of Becton, Dickinson
Table Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Becton, Dickinson 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units) and Growth Rate of Becton, Dickinson 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Production (K Units) and United States Market Share of Becton, Dickinson 2011-2016
Table Becton, Dickinson Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table BioMérieux Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Infectious Disease Testing Picture and Specifications of BioMérieux
Table Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of BioMérieux 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units) and Growth Rate of BioMérieux 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Production (K Units) and United States Market Share of BioMérieux 2011-2016
Table BioMérieux Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table Biocartis Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Infectious Disease Testing Picture and Specifications of Biocartis
Table Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Biocartis 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units) and Growth Rate of Biocartis 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Production (K Units) and United States Market Share of Biocartis 2011-2016
Table Biocartis Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table BioHelix Corporation Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Infectious Disease Testing Picture and Specifications of BioHelix Corporation
Table Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of BioHelix Corporation 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units) and Growth Rate of BioHelix Corporation 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Production (K Units) and United States Market Share of BioHelix Corporation 2011-2016
Table BioHelix Corporation Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table BioTheranostics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Infectious Disease Testing Picture and Specifications of BioTheranostics
Table Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of BioTheranostics 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units) and Growth Rate of BioTheranostics 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Production (K Units) and United States Market Share of BioTheranostics 2011-2016
Table BioTheranostics Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table Cepheid Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Infectious Disease Testing Picture and Specifications of Cepheid
Table Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Cepheid 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units) and Growth Rate of Cepheid 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Production (K Units) and United States Market Share of Cepheid 2011-2016
Table Cepheid Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table EraGen Biosciences Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Infectious Disease Testing Picture and Specifications of EraGen Biosciences
Table Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of EraGen Biosciences 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units) and Growth Rate of EraGen Biosciences 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Production (K Units) and United States Market Share of EraGen Biosciences 2011-2016
Table EraGen Biosciences Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table GenMark Diagnostics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Infectious Disease Testing Picture and Specifications of GenMark Diagnostics
Table Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of GenMark Diagnostics 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units) and Growth Rate of GenMark Diagnostics 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Production (K Units) and United States Market Share of GenMark Diagnostics 2011-2016
Table GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table Genomix Biotech Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Infectious Disease Testing Picture and Specifications of Genomix Biotech
Table Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Genomix Biotech 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units) and Growth Rate of Genomix Biotech 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Production (K Units) and United States Market Share of Genomix Biotech 2011-2016
Table Genomix Biotech Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table Gen-Probe Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Infectious Disease Testing Picture and Specifications of Gen-Probe
Table Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Gen-Probe 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units) and Growth Rate of Gen-Probe 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Production (K Units) and United States Market Share of Gen-Probe 2011-2016
Table Gen-Probe Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table Genomica S.A.U. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Infectious Disease Testing Picture and Specifications of Genomica S.A.U.
Table Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Genomica S.A.U. 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units) and Growth Rate of Genomica S.A.U. 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Production (K Units) and United States Market Share of Genomica S.A.U. 2011-2016
Table Genomica S.A.U. Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table Great Basin Corporation Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Infectious Disease Testing Picture and Specifications of Great Basin Corporation
Table Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Great Basin Corporation 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units) and Growth Rate of Great Basin Corporation 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Production (K Units) and United States Market Share of Great Basin Corporation 2011-2016
Table Great Basin Corporation Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table Illumina Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Infectious Disease Testing Picture and Specifications of Illumina
Table Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Illumina 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units) and Growth Rate of Illumina 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Production (K Units) and United States Market Share of Illumina 2011-2016
Table Illumina Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table Life Technologies Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Infectious Disease Testing Picture and Specifications of Life Technologies
Table Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Life Technologies 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Capacity (K Units), Production (K Units) and Growth Rate of Life Technologies 2011-2016
Figure Molecular Diagnostics in Infectious Disease Testing Production (K Units) and United States Market Share of Life Technologies 2011-2016
Table Life Technologies Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table Molecular Diagnostics in Infectious Disease Testing Price by Regions 2011-2016
Table Molecular Diagnostics in Infectious Disease Testing Price by Product Types 2011-2016
Table Molecular Diagnostics in Infectious Disease Testing Price by Companies 2011-2016
Table Molecular Diagnostics in Infectious Disease Testing Gross Margin by Companies 2011-2016
Table Price Comparison of Molecular Diagnostics in Infectious Disease Testing by Regions 2011-2016 (USD/Unit)
Table Price of Different Molecular Diagnostics in Infectious Disease Testing Product Types (USD/Unit)
Table Market Share of Different Molecular Diagnostics in Infectious Disease Testing Price Level
Table Gross Margin of Different Molecular Diagnostics in Infectious Disease Testing Applications
Table Marketing Channels Status of Molecular Diagnostics in Infectious Disease Testing
Table Traders or Distributors of Molecular Diagnostics in Infectious Disease Testing with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Molecular Diagnostics in Infectious Disease Testing (USD/Unit) in 2015
Table United States Import, Export, and Trade of Molecular Diagnostics in Infectious Disease Testing (K Units)
Figure United States Capacity (K Units), Production (K Units) and Growth Rate of Molecular Diagnostics in Infectious Disease Testing 2016-2021
Figure United States Capacity Utilization Rate of Molecular Diagnostics in Infectious Disease Testing 2016-2021
Table United States Molecular Diagnostics in Infectious Disease Testing Production by Type 2016-2021 (K Units)
Table United States Molecular Diagnostics in Infectious Disease Testing Production Market Share by Type 2016-2021
Figure United States Production Market Share of Molecular Diagnostics in Infectious Disease Testing by Type in 2021
Figure United States Sales (K Units) and Growth Rate of Molecular Diagnostics in Infectious Disease Testing 2016-2021
Figure United States Sales Revenue (Million USD) and Growth Rate of Molecular Diagnostics in Infectious Disease Testing 2016-2021
Figure United States Sales of Molecular Diagnostics in Infectious Disease Testing by Applications 2016-2021 (K Units)
Table United States Production Market Share of Molecular Diagnostics in Infectious Disease Testing by Applications 2016-2021
Figure United States Production Market Share of Molecular Diagnostics in Infectious Disease Testing by Applications in 2021
Table United States Production, Import, Export and Consumption of Molecular Diagnostics in Infectious Disease Testing 2016-2021 (K Units)
Table United States Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Molecular Diagnostics in Infectious Disease Testing 2016-2021
Table Major Raw Materials Suppliers of Molecular Diagnostics in Infectious Disease Testing with Contact Information
Table Manufacturing Equipment Suppliers of Molecular Diagnostics in Infectious Disease Testing with Contact Information
Table Major Players of Molecular Diagnostics in Infectious Disease Testing with Contact Information
Table Key Consumers of Molecular Diagnostics in Infectious Disease Testing with Contact Information
Table Supply Chain Relationship Analysis of Molecular Diagnostics in Infectious Disease Testing
Table New Project SWOT Analysis of Molecular Diagnostics in Infectious Disease Testing
Table New Project Investment Feasibility Analysis of Molecular Diagnostics in Infectious Disease Testing
Table Part of Interviewees Record List
Similar Reports
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.
Summary
This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...
- Publish Date: February 7, 2017
- $750
Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200.
Summary
This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...
- Publish Date: February 7, 2017
- $750
This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Con...
- Publish Date: February 7, 2017
- $750
